Stryker Receives FDA Clearance for Q Guidance System for Spine Applications
May 31 2022 - 8:59AM
Business Wire
Innovative planning and intraoperative platform
designed to be a procedural ecosystem for surgeons and their
patients during image-guided surgery
Stryker (NYSE:SYK) today announced that its Q Guidance System
received 510(k) clearance from the U.S. Food and Drug
Administration. The System, when used with the Spine Guidance
Software, is an advanced planning and intraoperative guidance
system designed to enable open or percutaneous computer-assisted
surgery. The Spine Guidance Software is the first spine navigation
software to receive clearance from the FDA for use with pediatric
patients aged 13 and older.
Stryker’s Q Guidance System aims to deliver surgical spine
planning and navigation capability through multiple tracking
options, sophisticated software algorithms and smart
instrumentation. It features a high-performance navigation camera
built on the company’s 20 years of experience developing guidance
technologies. Q Guidance features completely redesigned software
applications, semi-automatic and automatic segmentation features,
gesture recognition, and broad compatibility with various types of
image sets. When used with Airo TruCT mobile CT scanner, this
ecosystem delivers automatic image registration and pairs high
performance tracking capabilities with cutting edge intraoperative
image quality and scan volume.
“The versatility of the Q Guidance System will help to
streamline our technologies across multiple specialties such as
cranial, spine, ENT and orthopaedics,” said Robbie Robinson,
President of the Spine division. “The System is designed for future
compatibility with a fully integrated ecosystem, driving more value
for our customers. With a robust product pipeline in place, we are
positioned to provide a well-rounded, end-to-end platform for our
surgeon customers, with the ability to incorporate robotics and
intelligent handheld instruments in the future.”
About Stryker
Stryker is one of the world’s leading medical technology
companies and, together with its customers, is driven to make
healthcare better. The company offers innovative products and
services in Orthopaedics, Medical and Surgical, and Neurotechnology
and Spine that help improve patient and hospital outcomes. More
information is available at www.stryker.com.
Content ID: QGS-PR-1_33501
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220531005360/en/
Andrea Sampson, Sampson Public Relations Group 562.304.0301
asampson@sampsonprgroup.com
Stryker (NYSE:SYK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Stryker (NYSE:SYK)
Historical Stock Chart
From Jul 2023 to Jul 2024